Adaptimmune Therapeutics Plc logo

Adaptimmune Therapeutics Plc Share Price Today

(NASDAQ: ADAP)

Adaptimmune Therapeutics Plc share price is $0.24 & ₹20.51 as on 18 Apr 2025, 2.30 'hrs' IST

$0.24

Market is closed - opens 7 PM, 21 Apr 2025

View live Adaptimmune Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Adaptimmune Therapeutics Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Adaptimmune Therapeutics Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Adaptimmune Therapeutics Plc share price movements

  • Today's Low: $0.24
    Today's High: $0.25

    Day's Volatility :4.35%

  • 52 Weeks Low: $0.20
    52 Weeks High: $1.48

    52 Weeks Volatility :86.82%

Adaptimmune Therapeutics Plc (ADAP) Returns

PeriodAdaptimmune Therapeutics PlcSector (Health Care)Index (Russel 2000)
3 Months
-58.21%
-2.8%
0.0%
6 Months
-71.09%
-11.0%
0.0%
1 Year
-75.61%
-1.9%
0.0%
3 Years
-87.53%
-1.5%
-12.9%

Adaptimmune Therapeutics Plc (ADAP) Key Statistics

in dollars & INR

Previous Close
$0.24
Open
$0.2461
Today's High
$0.2461
Today's Low
$0.2354
Market Capitalization
$61.3M
Today's Volume
$302.0K
52 Week High
$1.48
52 Week Low
$0.1951
Revenue TTM
$178.0M
EBITDA
$-41.2M
Earnings Per Share (EPS)
$-0.3
Profit Margin
-39.78%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-275.74%

How to invest in Adaptimmune Therapeutics Plc Stock (ADAP) from India?

It is very easy for Indian residents to invest directly in Adaptimmune Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Adaptimmune Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Adaptimmune Therapeutics Plc or ADAP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Adaptimmune Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Adaptimmune Therapeutics Plc shares which would translate to 3.561 fractional shares of Adaptimmune Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Adaptimmune Therapeutics Plc, in just a few clicks!

Returns in Adaptimmune Therapeutics Plc (ADAP) for Indian investors in Rupees

The Adaptimmune Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Adaptimmune Therapeutics Plc investment value today

Current value as on today

₹26,831

Returns

₹73,169

(-73.17%)

Returns from Adaptimmune Therapeutics Plc Stock

₹75,510 (-75.51%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Adaptimmune Therapeutics Plc (ADAP)

52%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Adaptimmune Therapeutics Plc Stock from India on INDmoney has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Adaptimmune Therapeutics Plc

  • EcoR1 Capital, LLC

    10.65%

  • Long Focus Capital Management, LLC

    7.97%

  • NEA Management Company, LLC

    6.64%

  • Two Seas Capital LP

    5.77%

  • Baillie Gifford & Co Limited.

    4.59%

  • Mpm Asset Management, LLC

    2.16%

Analyst Recommendation on Adaptimmune Therapeutics Plc

Rating
Trend

Buy

    69%Buy

    23%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Adaptimmune Therapeutics Plc(by analysts ranked 0 to 5 stars)

Analyst Forecast on Adaptimmune Therapeutics Plc Stock (ADAP)

What analysts predicted

Upside of 610.96%

Target:

$1.71

Current:

$0.24

Insights on Adaptimmune Therapeutics Plc Stock (Ticker Symbol: ADAP)

  • Price Movement

    In the last 7 days, ADAP stock has moved up by 8.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 128.23M → 3.22M (in $), with an average decrease of 80.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 69.52M → -74.21M (in $), with an average decrease of 223.3% per quarter
  • ADAP vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 151.5%
  • ADAP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 116.4%
  • Price to Sales

    ForADAP every $1 of sales, investors are willing to pay $0.3, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

ADAP Adaptimmune Therapeutics Plc Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$178.0M
↑ 195.34%
Net Income
$-70.8M
↓ 37.81%
Net Profit Margin
-39.78%
↑ 149.12%

Adaptimmune Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Adaptimmune Therapeutics Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Adaptimmune Therapeutics Plc (ADAP) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Adaptimmune Therapeutics Plc logo
-14.29%
-71.09%
-75.61%
-87.53%
-93.35%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Adaptimmune Therapeutics Plc

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the treatment of head and neck cancer. The company also focuses on the development of T-cell therapies directed to PRAME (ADP-600) and CD70 (ADP-520). It has strategic collaboration with Galapagos to clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel produced on Galapagos' decentralized manufacturing platform (ADP-5701) in patients with head and neck cancer; collaboration and license agreement with Noile-Immune Biotech, Inc. and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Organization
Adaptimmune Therapeutics Plc
Employees
506
CEO
Mr. Adrian G. Rawcliffe
Industry
Health Technology

Management People of Adaptimmune Therapeutics Plc

NameTitle
Mr. Adrian G. Rawcliffe
CEO, Principal Accounting Officer & Director
Mr. William C. A. Bertrand Jr., Esq., J.D.
COO & Chief Compliance Officer
Dr. Elliot Norry B.A., M.D.
Chief Medical Officer
Ms. Joanna Brewer Ph.D.
Chief Scientific Officer
Dr. Juli P. Miller Ph.D.
VP of Corporate Affairs & Investor Relations
Ms. Kerry Sharp
Senior VP & General Council
Ms. Dana Lynch
Senior Director of Corporate Communications
Mr. John Lunger
Chief Patient Supply Officer
Mr. Dennis Williams
Senior Vice President of Late Stage Development
Ms. Cintia Piccina Pharm.D.
Chief Commercial Officer

Important FAQs about investing in ADAP Stock from India :

What is Adaptimmune Therapeutics Plc share price today?

Adaptimmune Therapeutics Plc share price today stands at $0.24, Open: $0.25 ; Previous Close: $0.24 ; High: $0.25 ; Low: $0.24 ; 52 Week High: $1.48 ; 52 Week Low: $0.20.

The stock opens at $0.25, after a previous close of $0.24. The stock reached a daily high of $0.25 and a low of $0.24, with a 52-week high of $1.48 and a 52-week low of $0.20.

Can Indians buy Adaptimmune Therapeutics Plc shares?

Yes, Indians can invest in the Adaptimmune Therapeutics Plc (ADAP) from India.

With INDmoney, you can buy Adaptimmune Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Adaptimmune Therapeutics Plc at zero transaction cost.

How can I buy Adaptimmune Therapeutics Plc shares from India?

It is very easy to buy Adaptimmune Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Adaptimmune Therapeutics Plc (ADAP) be purchased?

Yes, you can buy fractional shares of Adaptimmune Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Adaptimmune Therapeutics Plc stocks?

To start investing in Adaptimmune Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Adaptimmune Therapeutics Plc Stock (ADAP)?

Today’s highest price of Adaptimmune Therapeutics Plc (ADAP) is $0.25.

Today’s lowest price of Adaptimmune Therapeutics Plc (ADAP) is $0.24.

What is today's market capitalisation of Adaptimmune Therapeutics Plc?

Today's market capitalisation of Adaptimmune Therapeutics Plc ADAP is 61.3M

What is the 52 Week High and Low Range of Adaptimmune Therapeutics Plc Stock (ADAP)?

  • 52 Week High

    $1.48

  • 52 Week Low

    $0.20

What are the historical returns of Adaptimmune Therapeutics Plc (ADAP)?

  • 1 Month Returns

    -14.29%

  • 3 Months Returns

    -71.09%

  • 1 Year Returns

    -75.61%

  • 5 Years Returns

    -93.35%

Who is the Chief Executive Officer (CEO) of Adaptimmune Therapeutics Plc ?

Mr. Adrian G. Rawcliffe is the current Chief Executive Officer (CEO) of Adaptimmune Therapeutics Plc.